Overview

Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The objectives of this study were to characterize the effects of food on the pharmacokinetics (PK) and tolerability of BIA 9-1067 in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Opicapone